These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

2051 related items for PubMed ID: 17240920

  • 1. [Novel vaccines against M. tuberculosis].
    Okada M.
    Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
    [Abstract] [Full Text] [Related]

  • 2. DNA vaccine using hemagglutinating virus of Japan-liposome encapsulating combination encoding mycobacterial heat shock protein 65 and interleukin-12 confers protection against Mycobacterium tuberculosis by T cell activation.
    Yoshida S, Tanaka T, Kita Y, Kuwayama S, Kanamaru N, Muraki Y, Hashimoto S, Inoue Y, Sakatani M, Kobayashi E, Kaneda Y, Okada M.
    Vaccine; 2006 Feb 20; 24(8):1191-204. PubMed ID: 16216394
    [Abstract] [Full Text] [Related]

  • 3. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M, Shirakawa T.
    Kekkaku; 2005 Sep 20; 80(9):613-29. PubMed ID: 16245793
    [Abstract] [Full Text] [Related]

  • 4. [Anti-tuberculosis immunity by cytotoxic T cells * granulysin and the development of novel vaccines (HSP-65 DNA+IL-12 DNA)].
    Okada M, Kita Y.
    Kekkaku; 2010 Jun 20; 85(6):531-8. PubMed ID: 20662249
    [Abstract] [Full Text] [Related]

  • 5. Novel recombinant BCG and DNA-vaccination against tuberculosis in a cynomolgus monkey model.
    Kita Y, Tanaka T, Yoshida S, Ohara N, Kaneda Y, Kuwayama S, Muraki Y, Kanamaru N, Hashimoto S, Takai H, Okada C, Fukunaga Y, Sakaguchi Y, Furukawa I, Yamada K, Inoue Y, Takemoto Y, Naito M, Yamada T, Matsumoto M, McMurray DN, Cruz EC, Tan EV, Abalos RM, Burgos JA, Gelber R, Skeiky Y, Reed S, Sakatani M, Okada M.
    Vaccine; 2005 Mar 18; 23(17-18):2132-5. PubMed ID: 15755583
    [Abstract] [Full Text] [Related]

  • 6. Evaluation of a novel vaccine (HVJ-liposome/HSP65 DNA+IL-12 DNA) against tuberculosis using the cynomolgus monkey model of TB.
    Okada M, Kita Y, Nakajima T, Kanamaru N, Hashimoto S, Nagasawa T, Kaneda Y, Yoshida S, Nishida Y, Fukamizu R, Tsunai Y, Inoue R, Nakatani H, Namie Y, Yamada J, Takao K, Asai R, Asaki R, Matsumoto M, McMurray DN, Dela Cruz EC, Tan EV, Abalos RM, Burgos JA, Gelber R, Sakatani M.
    Vaccine; 2007 Apr 20; 25(16):2990-3. PubMed ID: 17280753
    [Abstract] [Full Text] [Related]

  • 7. Novel prophylactic and therapeutic vaccine against tuberculosis.
    Okada M, Kita Y, Nakajima T, Kanamaru N, Hashimoto S, Nagasawa T, Kaneda Y, Yoshida S, Nishida Y, Nakatani H, Takao K, Kishigami C, Inoue Y, Matsumoto M, McMurray DN, Dela Cruz EC, Tan EV, Abalos RM, Burgos JA, Saunderson P, Sakatani M.
    Vaccine; 2009 May 26; 27(25-26):3267-70. PubMed ID: 19200841
    [Abstract] [Full Text] [Related]

  • 8. [Up-to-date understanding of tuberculosis immunity].
    Mitsuyama M, Akagawa K, Kobayashi K, Sugawara I, Kawakami K, Yamamoto S, Okada Z.
    Kekkaku; 2003 Jan 26; 78(1):51-5. PubMed ID: 12683337
    [Abstract] [Full Text] [Related]

  • 9. Therapeutic efficacy of a tuberculosis DNA vaccine encoding heat shock protein 65 of Mycobacterium tuberculosis and the human interleukin 2 fusion gene.
    Changhong S, Hai Z, Limei W, Jiaze A, Li X, Tingfen Z, Zhikai X, Yong Z.
    Tuberculosis (Edinb); 2009 Jan 26; 89(1):54-61. PubMed ID: 19056317
    [Abstract] [Full Text] [Related]

  • 10. Priming but not boosting with plasmid DNA encoding mycolyl-transferase Ag85A from Mycobacterium tuberculosis increases the survival time of Mycobacterium bovis BCG vaccinated mice against low dose intravenous challenge with M. tuberculosis H37Rv.
    Romano M, D'Souza S, Adnet PY, Laali R, Jurion F, Palfliet K, Huygen K.
    Vaccine; 2006 Apr 12; 24(16):3353-64. PubMed ID: 16488518
    [Abstract] [Full Text] [Related]

  • 11. [Recent progress in mycobacteriology].
    Okada M, Kobayashi K.
    Kekkaku; 2007 Oct 12; 82(10):783-99. PubMed ID: 18018602
    [Abstract] [Full Text] [Related]

  • 12. [Plasmid encoding human IL-12 improve protective efficacy of Mtb8.4 gene vaccine with signal sequence against infection of Mycobacterium Tuberculosis].
    Li H, Li R, Zhong S, Ren H.
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Apr 12; 23(4):291-4. PubMed ID: 17428378
    [Abstract] [Full Text] [Related]

  • 13. Immunogenicity and protective efficacy of a DNA vaccine encoding the fusion protein of mycobacterium heat shock protein 65 (Hsp65) with human interleukin-2 against Mycobacterium tuberculosis in BALB/c mice.
    Wang LM, Bai YL, Shi CH, Gao H, Xue Y, Jiang H, Xu ZK.
    APMIS; 2008 Dec 12; 116(12):1071-81. PubMed ID: 19133010
    [Abstract] [Full Text] [Related]

  • 14. An attenuated Salmonella-vectored vaccine elicits protective immunity against Mycobacterium tuberculosis.
    Wang QL, Pan Q, Ma Y, Wang K, Sun P, Liu S, Zhang XL.
    Vaccine; 2009 Nov 12; 27(48):6712-22. PubMed ID: 19733584
    [Abstract] [Full Text] [Related]

  • 15. Plasmid interleukin-23 (IL-23), but not plasmid IL-27, enhances the protective efficacy of a DNA vaccine against Mycobacterium tuberculosis infection.
    Wozniak TM, Ryan AA, Triccas JA, Britton WJ.
    Infect Immun; 2006 Jan 12; 74(1):557-65. PubMed ID: 16369012
    [Abstract] [Full Text] [Related]

  • 16. [A study of the protective effect of the DNA vaccine encoding tubercle antigen 85B with MPT64 in mice challenged with Mycobacterium tuberculosis].
    Luo XD, Zhu DY, Chen Q, Jiang Y, Jiang S, Yang C.
    Zhonghua Jie He He Hu Xi Za Zhi; 2004 Sep 12; 27(9):611-6. PubMed ID: 15498274
    [Abstract] [Full Text] [Related]

  • 17. A new vaccine against tuberculosis shows greater protection in a mouse model with progressive pulmonary tuberculosis.
    Castañon-Arreola M, López-Vidal Y, Espitia-Pinzón C, Hernández-Pando R.
    Tuberculosis (Edinb); 2005 Sep 12; 85(1-2):115-26. PubMed ID: 15687035
    [Abstract] [Full Text] [Related]

  • 18. The live Mycobacterium tuberculosis phoP mutant strain is more attenuated than BCG and confers protective immunity against tuberculosis in mice and guinea pigs.
    Martin C, Williams A, Hernandez-Pando R, Cardona PJ, Gormley E, Bordat Y, Soto CY, Clark SO, Hatch GJ, Aguilar D, Ausina V, Gicquel B.
    Vaccine; 2006 Apr 24; 24(17):3408-19. PubMed ID: 16564606
    [Abstract] [Full Text] [Related]

  • 19. Development of therapeutic and prophylactic vaccine against Tuberculosis using monkey and transgenic mice models.
    Kita Y, Okada M, Nakajima T, Kanamaru N, Hashimoto S, Nagasawa T, Kaneda Y, Yoshida S, Nishida Y, Nakatani H, Takao K, Kishigami C, Nishimatsu S, Sekine Y, Takamori Y, McMurray DN, De la Cruz EC, Tan EV, Abalos RM, Burgos JA, Saunderson P, Sakatani M.
    Hum Vaccin; 2011 Apr 24; 7 Suppl():108-14. PubMed ID: 21263229
    [Abstract] [Full Text] [Related]

  • 20. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H, Namba K.
    Kekkaku; 2006 Dec 24; 81(12):753-74. PubMed ID: 17240921
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 103.